Drugs / MEDI-547
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00796055 | Aug 2009 → Feb 2010 | cancer | MedImmune LLC | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEDI-547 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00796055 ↗ |
| Known as | 1c1-mcmmaf | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594481 ↗ |
| Route | Intravenous | “60 minute IV infusion” NCT00796055 ↗ |